中国医学科学院阜外医院Fuwai Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Beijing 北京市

   已发表研究

   • Lipopolysaccharide-binding proteins and vasodilator-stimulated phosphoproteins as novel screening biomarkers for advanced adenoma and colorectal cancer. Discover oncology, 2026
   • miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

2. Breast cancer

   Beijing 北京市

   已发表研究

   • Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox biology, 2025

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

3. Lung cancer

   Beijing 北京市

   已发表研究

   • CYBB identified as a key immune hub gene linking lung cancer and atrial fibrillation. Journal of cardiothoracic surgery, 2025
   • Role of statins in non-small cell lung cancer treatment: a systematic review and meta-analysis. BMJ open, 2025

   另有 4 项已发表研究

   PubMed 收录了 6 篇关于该疾病、并提及这家医院的论文。

4. Liver cancer

   Beijing 北京市

   已发表研究

   • The liver cancer due to non-alcoholic steatohepatitis attributable to metabolic risk factors in 204 countries and territories, 1990-2021: an age-period-cohort analysis from the Global Burden of Disease study. International journal of surgery (London, England), 2026
   • Bioengineered Exosome-Magnetic Nanoplatform for Precision Therapy of Hepatocellular Carcinoma via Dual-Targeted Drug Delivery. International journal of nanomedicine, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

5. Stomach cancer

   Beijing 北京市

   已发表研究

   • Advanced therapies for stomach cancer. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2025
   • Ditrioxzin synergizes with 2-deoxy-d-glucose to induce redox-dependent metabolic crisis in gastric cancer through dual targeting of peroxiredoxin 3 and glycolysis. Toxicology and applied pharmacology, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

6. Prostate cancer

   Beijing 北京市

   已发表研究

   • Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer. International journal of surgery (London, England), 2025
   • Discovery of Novel CBP/p300 and BRD4 Dual-Target PROTACs with Potent Antitumor Activity in Prostate Cancer. Journal of medicinal chemistry, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

7. Esophageal cancer

   Beijing 北京市

   已发表研究

   • STIP1 drives Metabolic Reprogramming in Esophageal Squamous Cell Carcinoma via AHCY-LDHA Axis. Exploration (Beijing, China), 2025
   • USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer. Cell death & disease, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。